Company intelligence / Profile preview

Sympatient

Hamburg, Hamburg, Germanysympatient.com ↗

Ownership: Private
Employees: ~54
Development stage: Other

Overview

Sympatient’s main product, Invirto®, is the world’s first evidence-based digital psychotherapy for anxiety disorders that can be used at home. It combines virtual reality exposure with app-based cognitive behavioral therapy and real therapist integration. Invirto® is approved as a DiGA (“Digitale Gesundheitsanwendung”) in Germany, meaning it can be prescribed by doctors and psychotherapists with costs covered by statutory health insurance. Clinical results show measurable improvements in anxiety symptoms; the solution has been recognized for its efficacy and innovation through multiple awards.

Therapeutic areas: Psychiatry
Modalities: Device (Virtual reality-based therapy)Non-pharmacological therapy (App-based cognitive behavioral therapy)Digital therapeutic (DTx)
Industry: Digital Health Medical Devices

Partnerships

Leading German statutory health insurers via integrated care contractsUniversitätsklinikum Schleswig-Holstein (originated from scientific study there)

Beyond the preview

Go deeper on Sympatient.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sympatient.

Explore the full profile